Skip to main content
main-content

Zeitschrift

International Journal of Clinical Pharmacy

International Journal of Clinical Pharmacy 4/2018

Ausgabe 4/2018

Special Issue on Pharmacovigilance

Inhaltsverzeichnis ( 29 Artikel )

01.08.2018 | Editorial | Ausgabe 4/2018

Overview of this issue: pharmacovigilance, what is new?

Linda Gore Martin, Yolande Hanssens, Vibhu Paudyal

01.08.2018 | Commentary | Ausgabe 4/2018

The role and strategy of ISoP in global pharmacovigilance

Sten Olsson, Mira Harrison-Woolrych

01.08.2018 | Commentary | Ausgabe 4/2018 Open Access

An historical overview over Pharmacovigilance

Giulia Fornasier, Sara Francescon, Roberto Leone, Paolo Baldo

01.08.2018 | Commentary | Ausgabe 4/2018 Open Access

Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology

Paolo Baldo, Sara Francescon, Giulia Fornasier

01.08.2018 | Commentary | Ausgabe 4/2018

Current trends in pharmacovigilance: value and gaps of patient reporting

Pedro Inácio, Afonso Cavaco, Marja Airaksinen

01.08.2018 | Commentary | Ausgabe 4/2018

Pharmacovigilance in developing countries (part I): importance and challenges

Shaimaa Elshafie, Iman Zaghloul, Anne Marie Roberti

01.08.2018 | Commentary | Ausgabe 4/2018

Pharmacovigilance in developing countries (part II): a path forward

Shaimaa Elshafie, Anne Marie Roberti, Iman Zaghloul

01.08.2018 | Commentary | Ausgabe 4/2018

Overview of pharmacovigilance practices at the largest academic healthcare system in the State of Qatar

Moza Al Hail, Wessam Elkassem, Anas Hamad, Pallivalappila Abdulrouf, Binny Thomas, Derek Stewart

01.08.2018 | Commentary | Ausgabe 4/2018

The role of the suspicious renal pharmacist in identifying unusual adverse drug reactions—why this is not a small problem

Carolyn Vera Coulter

01.08.2018 | Commentary | Ausgabe 4/2018 Open Access

EU pharmacovigilance regulatory requirements of anticancer biosimilar monoclonal antibodies

Sara Francescon, Giulia Fornasier, Paolo Baldo

01.08.2018 | Commentary | Ausgabe 4/2018

Learning the effects of psychotropic drugs during pregnancy using real-world safety data: a paradigm shift toward modern pharmacovigilance

Angela Lupattelli, Olav Spigset, Hedvig Nordeng

01.08.2018 | Commentary | Ausgabe 4/2018

Is pharmacovigilance of biologicals cost-effective?

Barbara Claus

01.08.2018 | Commentary | Ausgabe 4/2018

Pharmacovigilance in a rare disease: example of the VIGIAPATH program in pulmonary arterial hypertension

Marie-Camille Chaumais, Caroline O’Connell, Laurent Savale, Christophe Guignabert, Frédéric Perros, Xavier Jaïs, Olivier Sitbon, Marc Humbert, David Montani

01.08.2018 | Research Article | Ausgabe 4/2018 Open Access

Targeted therapies and adverse drug reactions in oncology: the role of clinical pharmacist in pharmacovigilance

G. Fornasier, M. Taborelli, S. Francescon, J. Polesel, M. Aliberti, P. De Paoli, P. Baldo

01.08.2018 | Commentary | Ausgabe 4/2018

Finasteride use during pregnancy and early neonatal outcome: a case report

Doua AlSaad, Ben H. Lee, Sawsan Al-Obaidly

01.08.2018 | Review Article | Ausgabe 4/2018

Potential negative impact of informing patients about medication side effects: a systematic review

Jimmy Jose, Lamia AlHajri

01.08.2018 | Review Article | Ausgabe 4/2018

Pharmacovigilance in China: development and challenges

Ying Zhao, Tiansheng Wang, Guangyao Li, Shusen Sun

01.08.2018 | Review Article | Ausgabe 4/2018 Open Access

Pharmacovigilance in oncology

Paolo Baldo, Giulia Fornasier, Laura Ciolfi, Ivana Sartor, Sara Francescon

01.08.2018 | Research Article | Ausgabe 4/2018

Reporting adverse drug reactions: contribution, knowledge and perception of German pharmacy professionals

Anna Laven, Katharina Schmitz, Wilhelm-Hubertus Franzen

01.08.2018 | Research Article | Ausgabe 4/2018

Using a cancer registry to capture signals of adverse events following immune and targeted therapy for melanoma

João P. Aguiar, Fábio Cardoso Borges, Rodrigo Murteira, Catarina Ramos, Emanuel Gouveia, Maria José Passos, Ana Miranda, Filipa Alves da Costa

01.08.2018 | Research Article | Ausgabe 4/2018

Development and validation of an algorithm to identify drug-induced anaphylaxis in the Beijing Pharmacovigilance Database

Ying Zhao, Haidong Lu, Sydney Thai, Xiaotong Li, John Hui, Huilin Tang, Suodi Zhai, Lulu Sun, Tiansheng Wang

01.08.2018 | Research Article | Ausgabe 4/2018 Open Access

Kidney function and use of nonsteroidal anti-inflammatory drugs among elderly people: a cross-sectional study on potential hazards for an at risk population

Sara Modig, Sölve Elmståhl

01.08.2018 | Research Article | Ausgabe 4/2018 Open Access

Community pharmacists’ knowledge and perspectives of reporting adverse drug reactions in Australia: a cross-sectional survey

Raymond Li, Colin Curtain, Luke Bereznicki, Syed Tabish Razi Zaidi

01.08.2018 | Research Article | Ausgabe 4/2018

Prevalence and characteristics of hospital inpatients with reported fluoroquinolone allergy

Geoffrey C. Wall, Matthew J. Taylor, Hayden L. Smith

01.08.2018 | Research Article | Ausgabe 4/2018

Healthcare professionals’ knowledge, attitude and practice towards adverse drug reaction (ADR) reporting at the health center level in Ethiopia

Mohammed Assen Seid, Asmamaw Emagn Kasahun, Bamlak Markos Mante, Saron Naji Gebremariam

01.08.2018 | Research Article | Ausgabe 4/2018

Comparison of different methods for causality assessment of adverse drug reactions

Sapan Kumar Behera, Saibal Das, Alphienes Stanley Xavier, Srinivas Velupula, Selvarajan Sandhiya

01.08.2018 | Research Article | Ausgabe 4/2018

Trends in reporting drug-associated liver injuries in Taiwan: a focus on amiodarone

Jun-Hong Ye, Yunn-Fang Ho, Angela W.-F. On, Wen-Wen Chen, Yen-Ming Huang, Wei-I. Huang, Yun-Wen Tang

01.08.2018 | Research Article | Ausgabe 4/2018

Traditional Chinese medicine and drug-induced anaphylaxis: data from the Beijing pharmacovigilance database

Xiaotong Li, Sydney Thai, Wenchao Lu, Shusen Sun, Huilin Tang, Suodi Zhai, Tiansheng Wang

01.08.2018 | Research Article | Ausgabe 4/2018

Cardiovascular and gastrointestinal safety of selective cyclooxygenase-2 inhibitors: a case/non-case study

Luis Hermenegildo Martin Arias, Antonio Martin Gonzalez, Rosario Sanz Fadrique, Esther Salgueiro, Maria Sainz

Aktuelle Ausgaben